Radar › Companies › Biopharma Outsourcing · Indiana
Radar · Biopharma Outsourcing in Indiana

Best Biopharma Outsourcing Companies in Indiana, United States

The 36 best Biopharma Outsourcing companies in Indiana, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: SpectronRx.

36companies tracked
$210.8Mdisclosed funding
0unicorns
12have raised
FLIAR INTELLIGENCE · BIOPHARMA OUTSOURCING × INDIANA

Our analysis of 50 Biopharma Outsourcing companies

$6.3b in tracked funding; 77% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

50companies analysed
77%cloud-native stacks
2025funding peak (by rounds)
2018median founding year
45median Fliar Index™
102kcombined LinkedIn audience
55%of audience held by top 3
4companies hiring publicly (12 mo)

Ranked: Best Biopharma Outsourcing companies in Indiana

#CompanyDisclosed fundingLast roundStageFounderFoundedTech stackPatents & IP focusRecent signals
1SpectronRx
Provider of therapeutic and diagnostic isotope solutions
45Funding top 21%Growth top 28%Moat top 45%News top 46%
All 11 signals ▾
Fundingtop 21%
Growthtop 28%
Moattop 45%
Newstop 46%
Markettop 47%
Talentbottom 49%
Patentsbottom 41%
Techbottom 37%
Globalbottom 35%
Partnersbottom 35%
Innovationbottom 23%
Funding: Raised $85.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr)
Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo
rank vs industry peers · Fliar Intelligence Index 45/100
$85M5 mo agoSeries CJohn Zehner
CEO
2004WordPressMySQLPHP+142 patents
Radium-226 extraction from phosphogypsum waste streams
—
2List Biotherapeutics
Provider of end to end development & manufacturing solutions for all stages of drug clinical trials
$48M53 mo agoSeries A—2021———
3INCOG BioPharma Services
CDMO focused on manufacturer of injectable drug product
$43M28 mo agoSeries CCory Lewis
CEO and President
2020WordPressMySQLPHP+27——
4Semafore Pharmaceuticals
Limited information available
$14M236 mo agoDeadpooledEdward L Jacobs
President & CEO
2000———
5YourEncore
Global consulting for GxP compliance, research, ethics review, and technology solutions
$8M179 mo agoAcquiredBrad Lawson
CEO & President
2003———
6Tri-Pac
Offers contract manufacturing, filling and packaging services
50Growth top 35%Innovation top 36%Product top 43%Funding bottom 49%
All 7 signals ▾
Growthtop 35%
Innovationtop 36%
Producttop 43%
Fundingbottom 49%
Techbottom 48%
Globalbottom 36%
Marketbottom 31%
Growth: Fresh capital in last 24 mo
Innovation: 4 product lines
rank vs industry peers · Fliar Intelligence Index 50/100
$6M6 mo agoSeed—2009Wix eCommerceWixSentry+12——
7PreClinOmics
Contract research organization (CRO) with expertise in Metabolic, Renal and Cardiovascular disease
$5M170 mo agoAcquired—2001———
8AIT Bioscience
Bioanalytical CRO specializing in LC-MS/MS techniques and ligand binding assays
$2M140 mo agoAcquired—2009———
9Syra Health
Provider of medical communications, value based care solutions, and staffing services
$1M52 mo agoPublic—2020Apple iCloud MailMicrosoft 365Zoho+20——
10Sunnylife Pharma
Drug R&D service company providing chemistry solutions for unmet medical needs
$500K122 mo agoFunding RaisedZhijian Lu
CEO
2012———

Top 12 Biopharma Outsourcing companies in Indiana

#1
Series C · Indianapolis, Indiana · founded 2004 · 93 employees
$85Mraised
▾

SpectronRx is a provider of therapeutic and diagnostic isotope solutions. It provides radionuclides and custom theranostic contract manufacturing like monoclonal antibody labelling, peptides, radiolabeling of molecules and chemical entities, and aptamers.

Fliar Intelligence Index™ 45how this company ranks against its industry peers
Funding
top 21%
Growth
top 28%
Moat
top 45%
News
top 46%
Market
top 47%
Talent
bottom 49%
Funding: Raised $85.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Series C (Apr 2026)
Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo
Moat: Editorial + unicorn rating 4/10 · IP moat: 2 patents
Audience (LinkedIn): 7k LinkedIn followers — 7.3% of this cohort's audience
Funding rounds
  • Apr 2026Series C$85M
Founders & team
John ZehnerCEO
Investors
Orbimed
Tech stack
DiviGaugesGodaddyGoogle Font ApiHstsHttp/3
#2
Seed · South Bend, Indiana · founded 2009 · 122 employees
$5.6Mraised
▾

Offers contract manufacturing, filling and packaging services

Fliar Intelligence Index™ 50how this company ranks against its industry peers
Growth
top 35%
Innovation
top 36%
Product
top 43%
Funding
bottom 49%
Tech
bottom 48%
Global
bottom 36%
Growth: Fresh capital in last 24 mo
Innovation: 4 product lines
Product: 4 distinct product lines · Company stage: Seed
Audience (LinkedIn): 17k LinkedIn followers — 16.7% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Strategic HR Manager
Funding rounds
  • Feb 2026Seed$5.5M
  • Oct 2020Grant (prize money)$100K
Investors
IN.gov, Conexus Indiana
Tech stack
BootstrapGodaddyGoogle CloudGoogle Cloud CdnGsapHsts
#3
Series C · Indiana · founded 2020 · 70 employees
$42.9Mraised
▾

CDMO focused on manufacturer of injectable drug product

LinkedIn Pulse recent public activity · Jul 2026
Audience: 19k LinkedIn followers — 19.1% of this cohort's audience · 30 engagements/post (1.6× cohort median)
Hiring: 1 hiring post in 12 mo (public) · hiring: Inspection Associate, Manufacturing Engineering Technician
Funding rounds
  • May 2024Series C$42.9M
  • Apr 2022Conventional Debt—
  • Apr 2022Series B$15M
  • Sep 2020Series B$28.8M
Founders & team
Cory LewisCEO and PresidentTedd GreenCo-Founder & COO
Tech stack
Anime.JsApache Http ServerCdnjsCloudflareCloudflare Bot ManagementCore-Js
#4
Series A · Fishers, Indiana · founded 2021
$48.4Mraised
▾

Provider of end to end development & manufacturing solutions for all stages of drug clinical trials

Investors
Hana Ventures, DSC Investment, Paratus Investment
#5
Deadpooled · Westfield, Indiana · founded 2000
$13.5Mraised
▾

Limited information available

Funding rounds
  • Jan 2007Series B$9.5M
  • 2004Grant (prize money)$4M
Founders & team
Edward L JacobsPresident & CEO
Investors
8 Plus Ventures
#6
Acquired · Indianapolis, Indiana · founded 2003 · 299 employees
$7.5Mraised
▾

Global consulting for GxP compliance, research, ethics review, and technology solutions. The organization offers comprehensive consulting services to address GxP compliance needs throughout the development journey, from early discovery to global portfolio management. It establishes, plans, reviews, and corrects GxP quality requirements for current and future studies, supporting research organizations of any size worldwide. Expertise covers GCP, GCLP, GLP, GMP, GVP, CSV, and more, with a global reach spanning numerous countries. Services include on-site, hybrid, and remote audits, quality management system development, ICH GCP readiness, inspection preparation, and staffing for quality management. The company provides solutions for ethics reviews, study design, startup, enrollment, and offers technology solutions like CTMS, eSource + EDC, and eReg. It leverages data and AI through its Braid engine, offering products like CIRBI, OnCore, and Clinical Conductor. The company supports sponsors, CROs, and research sites with services including research staffing, training, and compliance.

Funding rounds
  • Oct 2011Series A$7.5M
Founders & team
Brad LawsonCEO & President
Investors
Accel-KKR
#7
Acquired · Indianapolis, Indiana · founded 2001 · 13 employees
$4.9Mraised
▾

PreClinOmics is a preclinical CRO with expertise in Metabolic, Renal and Cardiovascular disease, offering extensive analytical services and model development. It specializes in the design and execution of client studies in research areas such as metabolic syndrome, obesity, diabetes, cardiovascular, renal (including polycystic kidney disease), and neurology. It has In-house breeding programs which provide animal models for Metabolic Disease (ZDSD rat and FATZO mouse) and Polycystic Kidney Disease (pcy and jck mouse) research. It services include in-vivo preclinical discovery, Analytical, Pharmacokinetics/ADME and Safety/Toxicology services. As of March 2016, it operates as a subsidiary of Crown Bioscience.

Funding rounds
  • Jun 2012Grant (prize money)$1.3M
  • Jul 2008Grant (prize money)$1.5M
  • Feb 2008Grant (prize money)$1M
  • Dec 2005Grant (prize money)$1M
Investors
HHS
#8
Public · Carmel, Indiana · founded 2020 · 78 employees
$1Mraised
▾

Provider of medical communications, value based care solutions, and staffing services

LinkedIn Pulse recent public activity · Jul 2026
Audience: 20k LinkedIn followers — 19.5% of this cohort's audience
Funding rounds
  • May 2022Seed$1M
Tech stack
Amazon AlbAmazon SesAmazon Web ServicesApple Icloud MailBootstrapCloudflare
#9
Acquired · Indianapolis, Indiana · founded 2009 · 51 employees
$1.5Mraised
▾

AIT Bioscience offers bioanalytical contract research services for pre-clinical and phase I to III clinical trials. The company provides drug discovery analysis, protein analysis, and uses ligand-binding assays to provide immunogenicity information to support clinical and non-clinical studies. It employs electronic systems that detect and resolve potential deviations and errors in real time. The company has significant expertise in LC-MS/MS based techniques and has a collaboration with Crown Bioscience, an in vivo, drug discovery CRO for a 3-way study relationship. The company also claims to be the first CRO to go completely paperless.

Funding rounds
  • Jan 2015Series A$500K
  • Jan 2014Series A$1M
Investors
Elevate Ventures
#10
Funding Raised · Indianapolis, Indiana · founded 2012 · 3 employees
$500Kraised
▾

Drug R&D service company providing chemistry solutions for unmet medical needs. They assist drug discovery and development activities with partners worldwide, offering chemistry in/out-sourcing services. Their fundamental approach is to provide solutions to clients who address the unmet medical needs of patients. They strive to assist the discovery and development of innovative, high-quality preclinical candidates, enabling partners to carry out successful clinical trials for new medicines. They focus on medicinal chemistry and offer research support to impact pipelines. Founded by veteran scientists, they aim to make a mark by addressing unmet medical needs to help patients cope with various diseases. They carry out chemistry for clients in drug discovery research.

Funding rounds
  • Jul 2016Grant (prize money)$225K
  • Jun 2016Grant (prize money)$275K
Founders & team
Zhijian LuCEO
Investors
NIH, HHS
#11
Late Stage · Warsaw, Indiana · founded 2015
—raised
▾

Medical device & pharmaceutical consulting and staffing agency

Funding rounds
  • Jan 2022PE—
Founders & team
Tim EarlyCo-Founder & CEO
Investors
BPOC
#12
Seed · Indianapolis, Indiana · founded 2014 · 61 employees
—raised
▾

CDMO focused on manufacturing of viral vector products

LinkedIn Pulse recent public activity · Jul 2026
Audience: 10k LinkedIn followers — 10.2% of this cohort's audience
Activity: 1 partnerships (incl. World Orphan Drug Congress) announced in 12 mo
Funding rounds
  • Jan 2021Seed—
Investors
Ampersand Capital, BPOC
Tech stack
Animate.CssAosCdnjsCloudflareCloudflare Bot ManagementCookiebot

Funding & investor landscape

$210.8Mtotal disclosed funding
10companies funded
18disclosed rounds
0rounds last 90 days
Most active investors
HHS3 rounds
BPOC2 rounds
8 Plus Ventures1 rounds
Accel-KKR1 rounds
Ampersand Capital1 rounds
Black Diamond Capital Management1 rounds
Charles River Laboratories1 rounds
Conexus Indiana1 rounds
Constitution Capital Partners1 rounds
DSC Investment1 rounds

Notable founders

John Zehner
CEO · SpectronRx
Cory Lewis
CEO and President · INCOG BioPharma Services
Tedd Green
Co-Founder & COO · INCOG BioPharma Services
Edward L Jacobs
President & CEO · Semafore Pharmaceuticals
Brad Lawson
CEO & President · YourEncore
Zhijian Lu
CEO · Sunnylife Pharma
Tim Early
Co-Founder & CEO · Network Partners
Dave Watson
Founder & CEO · Resero Analytics
Bob Leasure
CEO & President · Inotiv
Prism market signals · United States · country-scoped Prism corpus, 1,368,075 docs

Market landscape — 10 sub-themes by coverage

Share of Biopharma Outsourcing coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

RESEARCH IN INDIANA · Health & Bio

How research on Biotechnology in Indiana is moving

A read on the academic research around Biotechnology in Indiana — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 43 papers.

43 papers · stance +0.50 · 56% breakthrough · 19% concern
breakthrough · advancement · concern
top institutions
  • Indiana University – Purdue University Indianapolis18
  • Indiana University Bloomington16
  • Indiana University School of Medicine14
  • Indiana University7
  • Indiana University Health6
leading researchers
Bolen, MacKenzie L. · Buendia, Marc · Salas, Azucena · Shi, Ji · Thompson, E. Aubrey · A. K. Mishra
prism intelligence · tone & topics
91% positive · 7% critical tone
PharmaceuticalsMedical ResearchHealthClinical TrialsBiologyGenetics
▲ Breakthroughs20 · 47%
▼ 50%→44% share
▼0.9× share momentum0 median citations80% since 2021mostly empirical
Breakthroughs are cooling (50%→44% of field), led by Transcription factor.
rising sub-themes (early→recent)
  • Transcription factor2
  • Transcription (linguistics)2
  • DNA-binding protein2
  • Gene expression2
  • DNA sequencing2
Landmark Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor acti · 558 cites
◆ Advancements9 · 21%
▼ 50%→19% share
▼0.4× share momentum0 median citations78% since 2021mostly empirical
Advancements are cooling (50%→19% of field), led by Extracellular matrix.
rising sub-themes (early→recent)
  • Extracellular matrix2
  • Gene expression2
  • Decellularization1
  • Keloid1
  • Gene knockdown1
Landmark A Mosaic Activating Mutation in AKT1 Associated with the Proteus Syndrome · 880 cites
▼ Concerns7 · 16%
▲ 0%→19% share
0 median citations100% since 2021mostly empirical
Concerns are rising (0%→19% of field), led by Antibody.
rising sub-themes (early→recent)
  • Antibody2
  • Wolbachia1
  • Immunoprecipitation1
  • Ankyrin repeat1
  • Drosophila melanogaster1
Landmark Food and Drug Administration Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 1, Nutrient Consider · 1 cites

Common questions

How many Biopharma Outsourcing companies are there in Indiana, United States?
Radar tracks 36 indexable Biopharma Outsourcing companies headquartered in Indiana, United States that meet our profile-completeness bar.
What is the total funding raised by Biopharma Outsourcing companies in Indiana, United States?
The Biopharma Outsourcing companies in Indiana, United States on this list have raised a combined $210.8M in disclosed equity funding across 10 funded companies.
Which is the highest-funded Biopharma Outsourcing company in Indiana, United States?
SpectronRx is the highest-funded Biopharma Outsourcing company in Indiana, United States, with $85M in disclosed equity funding.
How many Biopharma Outsourcing companies in Indiana, United States are funded?
10 of the 36 Biopharma Outsourcing companies in Indiana, United States on this list have disclosed at least one equity funding round.
How many Biopharma Outsourcing unicorns are there in Indiana, United States?
None of the Biopharma Outsourcing companies in Indiana, United States on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Indiana, United States Biopharma Outsourcing companies?
The most active investors in Indiana, United States Biopharma Outsourcing companies on this list include HHS, BPOC, 8 Plus Ventures, Accel-KKR, Ampersand Capital.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon